CAROLINE YERICH: Open Payments
NPI 1023023827 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,228 in 54 payments from 22 companies in 2025. Trend: 2023 $1,671 · 2024 $1,391 · 2025 $1,228
Food & beverage: $1,228
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $268 |
| ABBVIE INC. | 10 | $182 |
| AstraZeneca Pharmaceuticals LP | 7 | $145 |
| SANOFI-AVENTIS U.S. LLC | 3 | $79 |
| Lilly USA, LLC | 2 | $54 |
| PFIZER INC. | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Amgen Inc. | 2 | $43 |
| SHIELD THERAPEUTICS INC | 2 | $40 |
| Exact Sciences Corporation | 2 | $38 |
Products named: Ozempic, VRAYLAR, FARXIGA, TZIELD, Wegovy, UBRELVY, REXULTI, ACCRUFER.
Industry payments across SC — which companies pay providers there.
